Sign Up to like & get
recommendations!
0
Published in 2018 at "International journal of antimicrobial agents"
DOI: 10.1016/j.ijantimicag.2018.07.027
Abstract: In Pseudomonas aeruginosa (P. aeruginosa) collected from cystic fibrosis (CF) patients, 24% resistance to ceftazidime-avibactam in isolates negative for carbapenemases and extended-spectrum β-lactamases (ESBLs) has previously been observed. The current study aimed to unravel the…
read more here.
Keywords:
ceftazidime avibactam;
mexab oprm;
avibactam;
Sign Up to like & get
recommendations!
0
Published in 2018 at "Scientific Reports"
DOI: 10.1038/s41598-018-34694-z
Abstract: MexAB-OprM and MexEF-OprN are Pseudomonas aeruginosa efflux pumps involved in the development of antibiotic resistance. Several studies developed with laboratory strains or using a few clinical isolates have reported that the regulation system of MexEF-OprN…
read more here.
Keywords:
mexab oprm;
interplay;
clinical isolates;
mexef oprn ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0266742
Abstract: Pseudomonas aeruginosa has different resistant mechanisms including the constitutive MexAB-OprM efflux pump. Single nucleotide polymorphisms (SNPs) in the mexR, nalC, and nalD repressors of this efflux pump can contribute to antimicrobial resistance; however, it is…
read more here.
Keywords:
mexab oprm;
mexr nalc;
nalc nald;
genetic lineages ... See more keywords